SEATTLE--(BUSINESS WIRE)--Tasso, Inc., the leading provider of patient-centric, clinical-grade blood collection solutions, today announced that the TassoOne™ Plus, a new high-volume liquid blood ...
SEATTLE--(BUSINESS WIRE)--Tasso, Inc., the leading provider of patient-centric clinical-grade blood collection solutions, today announced it received CE Mark certification for its Tasso+™ device, a ...
Tasso has taken a major step forward in its plans to make quick, easy and widespread blood tests a reality, with an FDA clearance for its simple sample collection device. The Tasso+ lancet can be ...
The recent greenlight from European regulators to Tasso Inc. to market its Tasso+ device in the EU brings another solution to the market for blood collection Tasso has developed the Tasso+, a ...
Neurogen Biomarking Enters Partnership Agreement with Tasso to Bring Virtually Painless Blood Collection Technology to Its Alzheimer’s Testing Platform The collaboration positions Neurogen at the ...
Add Yahoo as a preferred source to see more of our stories on Google. Getty Images; Alyssa Powell/BI Needle-free devices like TAP and Tasso offer painless blood collection, a benefit for the squeamish ...
Tasso, a Seattle-based startup working on bringing blood testing to the home via a wearable patch-like device, has raised $6.1 million in Series A funding. Vertical Venture Partners led the round, ...
Tasso, which specializes in clinical-grade blood collection, is partnering with United BioSource to make sample collection and analysis more efficient and easier for patients taking part in clinical ...
Tasso, Inc. (US) is a leading player in the microsampling devices market, holding the largest market share in 2023. Since its inception, Tasso's products have been widely used in pharmaceutical ...
Needle-free devices like TAP and Tasso offer painless blood collection, a benefit for the squeamish. These tests face challenges with sample size and accuracy compared to traditional methods. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results